Washington Update, May 2024
Washington Update by Artemis Policy Group HHS Final Rules Strengthen Protections for People with Bleeding and Clotting Disorders Earlier this month, the Office for Civil Rights, within the Department of Health and Human Services (HHS), finalized a new rule which should improve access to behavioral health facilities for people with bleeding and clotting disorders. The […]
Washington Update, April 2024
Washington Update Hemophilia Alliance Hill Day Focuses on 340B and Alternative Funding Programs by Ellen Riker and Johanna Gray, Artemis Policy Group With the goal of educating Members of Congress on the importance of the 340B Drug Discount Program to Hemophilia Treatment Centers (HTCs) and the bleeding disorders community, 120 advocates headed to Capitol Hill […]
Washington Update, March 2024
Washington Update Congress Continues to Deliberate on 2024 Government Funding On March 8, Congress passed the first of two funding bills to extend federal funding for Departments and Agencies, including the FDA. This bill included a very small number of “riders” (popular authorizing policies outside the funding bills) in healthcare. Of interest to HTCs, is […]
Washington Update, February 2024
Advocacy and Legal Update Senators Release Draft Legislation to Reform the 340B Program: the SUSTAIN 340B Act by Elizabeth “Issie” Karan, Legal Counsel and Artemis Policy Group Earlier this month a group of bipartisan Senators released draft legislation focused on reforming the 340B Discount Drug Pricing Program. The Senators are seeking feedback on the legislative […]
Washington Update, January 2024
Washington Update by Ellen Riker & Johanna Gray, Artemis Policy Group, Hemophilia Alliance Advocacy Consultants Proposed Rule on Affordable Care Act Provisions Published Positive developments in lawsuit about copay accumulator adjustors – There have been two positive developments in the lawsuit challenging the HHS rule that allows copay accumulator adjustors. First, the judge in the […]
Washington Update, December 2023
Advocacy and Legal Update Future of Copay Accumulator Adjustor Programs Remain Up in the Air by Ellen Riker & Johanna Gray, Artemis Policy Group, Hemophilia Alliance Advocacy Consultants In October, the Alliance Newsletter included an article on the United States District Court for the District of Columbia ruling that insurers can no longer implement copay […]
Washington Update, November 2023
Advocacy Update 2025 NBPP Proposed Rule Released with Positive Policies for Bleeding Disorders Community by Johanna Gray, Artemis Policy Group, Hemophilia Alliance Advocacy Consultant On November 15, the Department of Health and Human Services (HHS) and the Centers for Medicare and Medicaid Services (CMS) released the Notice of Benefit and Payment Parameters (NBPP) proposed rule […]
Washington Update, October 2023
Washington Update CMS Allows Clotting Factor Add-On Payments for Inpatients Coded with New ICD-10 Diagnoses Codes for VWD by Ellen Riker, Artemis Policy Group, Hemophilia Alliance Advocacy Consultant In a Medicare Learning Network newsletter released on Oct 19, CMS notified providers that Medicare’s policy for allowing separate payment (outside the bundled hospital DRG payment) for […]
Washington Update, September 2023
Advocacy Update What’s happening in Congress? by Artemis Policy Group, Hemophilia Alliance Advocacy Consultants Congress returned to Washington after Labor Day with a jam-packed schedule for fall. Top of mind for everyone is the September 30th deadline to fund the federal government by passing all 12 appropriations bills for fiscal year (FY) 2024. If lawmakers […]
Washington Update, August 2023
Washington Update Congress Seeks Input on 340B Policies and Drug Shortages by Ellen Riker, Hemophilia Alliance Advocacy Consultant Senate RFI on 340B – Last month we reported on a Request for Information (RFI), issued by a bipartisan group of Senators, including Senators Tammy Baldwin (D-WI), Shelley Moore Capito (R-WV), Ben Cardin (D-MD), Jerry Moran (R-Ks), […]